Rentokil Initial’s revenues were up 4.9% in the first quarter, or 3.1% on an organic basis when stripping out the impact of acquisitions including HiCare in India.
North American growth “stabilised” in the quarter, the FTSE 100-listed group said, with organic revenues up 1.5% in the region. Latin America’s, the group’s second-largest market, saw organic revenue growth of 4.1%.
In the UK and Sub-Saharan Africa, revenues rose 4.1%, while in Asia they were up 4.3% and in the Pacific region they were up 7.3% during the quarter.
Chief executive Andy Ransom called it “a positive overall start to 2024”.